Psychedelic mushroom-containing chocolate exposures: Case series.
The American journal of emergency medicine November 1, 2024 Hayley T Gartner, Herbert Z Wan, Reeves E Simmons et al. 2 citations
Recreational use of psilocybin-containing mushroom chocolates is rising in the United States. A case series of 36 patients from three poison centers (2023–2024) found a median age of 17 years. Most exposures (64%) were intentional, including abuse or misuse. Common clinical effects included mental status changes (76%), paranoia or hallucinations (28%), dysrhythmias (19%), and gastrointestinal discomfort (17%); one seizure occurred. Effects typically lasted 3 to 24 hours. Treatments included intravenous fluids (50%) and benzodiazepines (19%). No fatalities were reported. While most cases were minor, some patients developed serious effects, highlighting the need for larger studies to identify factors influencing outcomes.